J&J’s Darzalex combination treatment for untreated multiple myeloma recommended by NICE
Around 33,000 people in the UK are currently living with multiple myeloma, an incurable type of blood cancer
- News
- Research
- Sales
- Regulatory
- Healthcare
- Marketing
AstraZeneca’s Tagrisso shows eight-year landmark survival in early-stage EGFR-mutated lung cancer
The results from a global phase 3 trial show the longest survival data ever reported in this setting
Lilly to acquire Merida Biosciences in deal worth up to $2.875bn
The acquisition is to advance treatments for serious autoimmune and allergic diseases
J&J’s Darzalex combination treatment for untreated multiple myeloma recommended by NICE
Around 33,000 people in the UK are currently living with multiple myeloma, an incurable type of blood cancer
Gilead opens new research centre bringing together oncology, inflammation and research data science teams
The centre in California supports the company’s $32bn US investment
CPHI Milan introduces new specialist zones
The event runs from 6-8 October 2026 at the Fiera Milano exhibition centre in Rho, Italy
Latest content
Inizio appoints Oisín Ó Gógáin as Chief People Officer
Ó Gógáin was most recently Aon’s Chief People Officer for the UK, Ireland and South Africa
Read More
Langland appoints Kathryn Stewart as Head of Strategy and promotes Diane Ross to Head of Scientific Practice
Stewart previously held roles at Saatchi & Saatchi Health London, part of the Publicis Health network, and Avalere, while Ross has been part of Publicis Health for over two decades
Read More
Novo Nordisk UK appoints George Godfrey as Senior Director, Medical & Regulatory
Godfrey previously served as Head of Medical for Respiratory and Immunology for AstraZeneca UK
Read More
Abivax has appointed Ivan Nuñez-Pacheco as Abivax Global Head of Patient Services
Nuñez-Pacheco most recently served as Senior Director of AbbVie Patient Services
Read More
Intelligence
Cell and gene therapies – moving from niche innovations towards broader clinical use
Looking at the regulatory challenges of cell and gene therapies for serious or life-threatening rare diseases
Read More
Creating a strong patent portfolio through constant communication
Why patenting should not stop at the drug candidate stage – and why coordination between researchers and attorneys is essential for strong protection
Read More
Leading through complexity
Strengthening strategic judgement during uncertainty – exploring the strategic concepts that matter most
Read More
The Amazon reckoning: GLP-1s and the consumer lifestyle shift – why the molecule is no longer enough
Amazon’s entry into the GLP-1 market should be a signal to pharma that it needs to shift focus from molecule to ‘Operating Model’
Read More
Lupus – moving patient care beyond current therapies towards resetting the immune system
Precision medicine is no longer theoretical, but increasingly achievable for people living with lupus
Read More
Forging a connection through creativity
A spark of creativity can cut through complexity, adding real value and helping to forge true connections with patients
Read More
Blogs
Latest
Next-Level Clinical Practice, Real-World Impact: Evolving Patient Simulation with the Clinical Readiness Studio
September 15, 2026 | Medscape Education|AI, CME, Clinical Readiness Studio, HcSimWeek, Health Simulation Week, MedEd
Healthcare is changing rapidly, bringing unprecedented data and complex treatment pathways to the point of care. Clinical mastery requires active experience, the confidence to make …
Medscape Sponsors The John Ritter Foundation’s “Evening From the Heart”
September 15, 2026 | Medscape Education|Aortic Dissection Awareness Week, Cardiology Education, Evening from the Heart, John Ritter Foundation for Aortic Health
When independent, evidence-based education directly connects with clinicians at the point of care, clinical practice changes. Driven by this vital mission, Medscape Education was proud …
Changing the narrative: why hidden struggles matter
September 10, 2026 | Mednet|Making Health Whole, Medical Communications, Suicide Prevention, healthcare innovation, whole health
On Suicide Prevention Day, we’re focusing on something often overlooked: the difference between what’s visible and what’s actually being carried. Many people living with long-term …
From Booth to Bavaria: A Recap of Impact at ESC 2026
September 7, 2026 | Medscape Education|CME, Cardiology Education, IME, Patient Impact, cardiology
We have officially wrapped up another year at ESC. For Medscape Education, 4 days on the ground confirmed what 3 decades of cardiovascular education have …
Supporting the people who support patients
August 28, 2026 | Mednet|Making Health Whole, Whole Health Communication, carers, healthcare communications
Supporting those who provide care can lead to improved experiences and health outcomes for everyone involved.
When what matters to patients is hard to measure
September 15, 2026 | Cuttsy + Cuttsy|EU HTA, JCA, JSC, Joint Clinical Assessment, Joint Scientific Consultation, clinical trials
Patient-relevant outcomes sit at the heart of the EU HTA reforms, but ensuring they reflect lived experience requires you to look beyond what traditional clinical …
Why phase 2 decisions are locking out pharma’s best launch positions
September 14, 2026 | Nmblr|Commercialisation strategy, Launch Performance, Success Factors, pharma launch, phase 2, positioning, value proposition
Half of the 2023 US pharmaceutical launch class missed pre-launch first-year forecasts . That gap is usually explained away as a data problem, a market …
Intelligent Commercialization™ across the pharma lifecycle
August 27, 2026 | Inizio|Intelligent Commercialization, Pharma, healthcare
Pharma teams are under growing pressure to navigate launch complexity, identify risks earlier, and engage HCPs more effectively.
Four steps to a smarter congress strategy: A practical guidebook
August 27, 2026 | Inizio|Intelligent Congress, Pharma, healthcare
This guidebook explores how Intelligent Congress helps pharma teams create more coordinated, measurable, and impactful congress strategies.
Permission to pause: making treatment breaks part of the cancer care conversation
August 5, 2026 | Cuttsy + Cuttsy|Cancer, Social Listening, Treatment breaks, Treatment pause, oncology
Exploring how empathetic, patient-centred communication can make planned treatment breaks easier to discuss as part of cancer care.